Sjogren's syndrome

10 trials 3 recruiting MedDRA PT
10 Registered trials
3 Recruiting
5 Unique sponsors
6 Unique IMPs
8 Commercial trials
Drug classes (ATC)
— ATC code not specified 8
L Oncology (ATC L) 2
P Parasitology (ATC P) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Monoclonal antibody 1 substance
JAK inhibitor 1 substance
Immunosuppressant 1 substance
Phase III: 6 Phase II: 4

Filter these 10 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 10 trials

Phase III

6 trials
  • Bristol-Myers Squibb Services Unlimited Company Commercial
    DEUCRAVACITINIB
    2023-503327-26-00 15 countries 2024 n=243
    Recruiting
  • Horizon Therapeutics Ireland Designated Activity Company Commercial
    DAZODALIBEP
    2023-503904-10-00 12 countries 2024 n=231
    Recruiting
  • Horizon Therapeutics Ireland Designated Activity Company Commercial
    DAZODALIBEP
    2023-503923-24-00 12 countries 2024 n=194
    Ended
  • Novartis Pharma AG Commercial
    IANALUMAB
    2022-502966-26-01 16 countries 2023 n=271
    Ended
  • Novartis Pharma AG Commercial
    IANALUMAB
    2024-511068-10-00 11 countries 2022 n=150
    Ended
  • Novartis Pharma AG Commercial
    IANALUMAB
    2024-511069-12-00 9 countries 2022 n=128
    Ended

Phase II

4 trials
  • Novartis Pharma AG Commercial
    IANALUMAB
    2023-508957-24-00 1 country 2022 n=20
    Ended
  • Novartis Pharma AG Commercial
    IANALUMAB
    2023-508996-35-00 7 countries 2024 n=69
    Recruiting
  • Assistance Publique Hopitaux De Paris Academic
    HYDROXYCHLOROQUINE SULFATE; LEFLUNOMIDE; MYCOPHENOLATE MOFETIL
    2023-510054-16-00 7 countries 2022 n=235
    Ended
  • Universitair Medisch Centrum Utrecht Academic
    HYDROXYCHLOROQUINE SULFATE; LEFLUNOMIDE
    2024-510904-36-00 1 country 2021 n=52
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 5 Phase II, Phase III 1
Horizon Therapeutics Ireland Designated Activity Company Commercial 2 Phase III 1
Bristol-Myers Squibb Services Unlimited Company Commercial 1 Phase III 1
Assistance Publique Hopitaux De Paris Academic 1 Phase II 0
Universitair Medisch Centrum Utrecht Academic 1 Phase II 0
New trials by year
2021
1
2022
4
2023
1
2024
4
← All indication landscapes